“The decision by AstraZeneca to carry out clinical trials using one of two vectors of Sputnik V in order to increase its own vaccine’s efficacy is an important step towards uniting efforts in the fight against the pandemic,” RDIF CEO Kirill Dmitriev stated. Sputnik V is 1 of the most productive vaccines globally with more than 90 per cent efficacy against coronavirus, RDIF stated.
Meanwhile, Russian Prime Minister Mikhail Mishustin pledged on Friday that the nation would start off COVID-19 vaccination at the finish of the week and authorities would not miss the deadline.
“I can say today that we meet the deadline. The first batches of the vaccine have already been sent to regions, we are gradually nearing the output targets,” Mishustin told coronavirus vaccine producers.
Russian President Vladimir Putin has ordered that mass vaccination be launched this week. On Thursday, Moscow Mayor Sergei Sobyanin stated that more than 6,000 residents of the Russian capital had currently been vaccinated. Doctors, teachers and social services staffers are the very first in line to get the vaccine.
(With inputs from Agencies)